HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yong Song Selected Research

Lung Diseases (Lung Disease)

6/2015Intratracheal administration of mitochondrial DNA directly provokes lung inflammation through the TLR9-p38 MAPK pathway.
10/2013[Expression of protein-tyrosine-phosphatase 1B in non-small-cell lung cancer and its prognostic significance].
5/2011[Expression and prognostic value of AKT2 in non-small cell lung cancer].
6/2010[The correlation between the expression of Wnt1 and prognosis in resected non-small cell lung cancer].
4/2008[Analysis of RASSF1A promoter hypermethylation in serum DNA of non-small cell lung cancer].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yong Song Research Topics

Disease

101Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 04/2008
85Neoplasms (Cancer)
07/2022 - 07/2004
57Lung Neoplasms (Lung Cancer)
02/2022 - 04/2008
31Adenocarcinoma of Lung
01/2022 - 10/2009
25Neoplasm Metastasis (Metastasis)
08/2021 - 09/2009
20Inflammation (Inflammations)
04/2022 - 09/2003
15Acute Lung Injury
04/2022 - 04/2003
13Lung Injury
04/2022 - 10/2009
12Carcinogenesis
07/2022 - 09/2009
10Disease Progression
10/2022 - 09/2013
9Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 01/2013
9Malignant Pleural Effusion
09/2019 - 01/2012
8Pneumonia (Pneumonitis)
01/2021 - 01/2014
8Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2021 - 09/2009
7Pleural Effusion (Pleural Effusions)
04/2020 - 01/2012
7Exanthema (Rash)
01/2020 - 01/2013
7Asthma (Bronchial Asthma)
01/2019 - 03/2007
7Hemorrhagic Shock
01/2009 - 04/2003
6Carcinoma (Carcinomatosis)
01/2022 - 09/2009
6Adenocarcinoma
12/2021 - 09/2009
6Endometriosis
01/2020 - 04/2013
5Sepsis (Septicemia)
04/2022 - 08/2002
5Brain Neoplasms (Brain Tumor)
02/2022 - 01/2017
5Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2020 - 01/2009
5Lymphatic Metastasis
01/2017 - 01/2009
5Lung Diseases (Lung Disease)
06/2015 - 04/2008
4Necrosis
01/2022 - 12/2006
4Food Hypersensitivity (Food Allergy)
02/2021 - 01/2017
4Hemorrhage
02/2021 - 04/2003
4Insulin Resistance
04/2016 - 11/2011
3Wounds and Injuries (Trauma)
06/2022 - 01/2013
3Breast Neoplasms (Breast Cancer)
06/2021 - 04/2015
3Granuloma
04/2020 - 06/2003
3Hypertension (High Blood Pressure)
01/2020 - 01/2013
3Hypoxia (Hypoxemia)
01/2019 - 01/2013

Drug/Important Bio-Agent (IBA)

34Biomarkers (Surrogate Marker)IBA
02/2022 - 07/2004
32Proteins (Proteins, Gene)FDA Link
04/2022 - 03/2009
26ErbB Receptors (EGF Receptor)IBA
08/2021 - 03/2011
14Tyrosine Kinase InhibitorsIBA
01/2022 - 03/2011
13Long Noncoding RNAIBA
09/2022 - 04/2015
12Immune Checkpoint InhibitorsIBA
01/2022 - 12/2017
10RNA (Ribonucleic Acid)IBA
06/2022 - 04/2004
9Biological ProductsIBA
02/2022 - 06/2012
9MicroRNAs (MicroRNA)IBA
08/2021 - 09/2012
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 09/2009
9Small Interfering RNA (siRNA)IBA
01/2020 - 11/2013
9Messenger RNA (mRNA)IBA
01/2019 - 09/2005
8CytokinesIBA
04/2022 - 07/2012
8PlatinumIBA
01/2021 - 03/2011
8icotinibIBA
02/2020 - 09/2013
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2017 - 04/2003
7LipopolysaccharidesIBA
01/2021 - 09/2005
6CrizotinibIBA
01/2020 - 01/2015
6Pharmaceutical PreparationsIBA
12/2019 - 07/2010
5Gefitinib (Iressa)FDA Link
12/2020 - 03/2011
5Cadherins (E-Cadherin)IBA
10/2019 - 11/2013
5CateninsIBA
02/2017 - 04/2015
4Topotecan (Hycamtin)FDA LinkGeneric
04/2022 - 10/2018
4Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2018
4Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 11/2012
4VimentinIBA
12/2021 - 11/2013
4Carcinoembryonic AntigenIBA
08/2021 - 04/2014
4osimertinibIBA
08/2021 - 01/2019
4AlbuminsIBA
03/2021 - 09/2014
4LigandsIBA
02/2021 - 04/2015
4Circulating Tumor DNAIBA
01/2021 - 04/2020
4DNA (Deoxyribonucleic Acid)IBA
01/2021 - 04/2008
4Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2021 - 03/2011
4Interleukin-6 (Interleukin 6)IBA
01/2021 - 07/2012
4Carboplatin (JM8)FDA LinkGeneric
01/2021 - 09/2014
4Farnesyltranstransferase (Farnesyltransferase)IBA
01/2021 - 01/2018
4Docetaxel (Taxotere)FDA Link
05/2020 - 07/2014
4Toll-Like Receptors (Toll-Like Receptor)IBA
01/2020 - 09/2005
4Mitochondrial DNA (mtDNA)IBA
11/2019 - 01/2013
4Anaplastic Lymphoma KinaseIBA
05/2018 - 01/2015
4HMGB1 Protein (HMG1)IBA
10/2017 - 09/2009
4enhanced green fluorescent proteinIBA
09/2012 - 07/2010
4Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
03/2012 - 08/2002
39 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA
04/2022 - 01/2019
3Phosphotransferases (Kinase)IBA
01/2022 - 05/2014
3GemcitabineFDA Link
01/2022 - 09/2014
3Tumor Biomarkers (Tumor Markers)IBA
12/2021 - 02/2019
3Anti-Bacterial Agents (Antibiotics)IBA
03/2021 - 09/2011
3Alanine Transaminase (SGPT)IBA
02/2021 - 01/2017
3AntibodiesIBA
01/2021 - 02/2009
3Pemetrexed (MTA)FDA Link
10/2020 - 02/2015
3ImmunosorbentsIBA
01/2020 - 05/2014
3EnzymesIBA
01/2020 - 05/2014
3growth arrest specific transcript 5IBA
11/2019 - 02/2016
3ORALIT (ORS)IBA
08/2019 - 10/2009
3Transcription Factors (Transcription Factor)IBA
01/2019 - 06/2014
3130-nm albumin-bound paclitaxelIBA
01/2019 - 09/2014
3Protein Isoforms (Isoforms)IBA
01/2018 - 01/2014
3AllergensIBA
10/2017 - 05/2011

Therapy/Procedure

35Drug Therapy (Chemotherapy)
01/2022 - 09/2009
34Therapeutics
10/2022 - 12/2008
12Immunotherapy
12/2021 - 03/2014
6Punctures
04/2022 - 09/2005
6Radiotherapy
01/2022 - 09/2009
5Artificial Respiration (Mechanical Ventilation)
02/2022 - 05/2014